• Policy
• Hanmi’s salt-modifying drug for Galvus, re-licensed
• by Lee, Tak-Sun Feb 17, 2021 05:39am

• Company
• SK Chemicals sells Janssen’s Ultracet
• by Lee, Seok-Jun Feb 17, 2021 05:39am

• Opinion
• [Reporter’s View] KDCA’s dilemma on using AZ vaccine
• by Kim, Jin-Gu Feb 17, 2021 05:39am

• Policy
• Novavax vaccine needed as AZ vaccine in 65 and up postponed
• by Lee, Tak-Sun Feb 16, 2021 06:08am

• InterView
• Takeda's evolution continues
• by Eo, Yun-Ho Feb 16, 2021 06:08am

• Policy
• COVID-19 vaccine lot release to be authorized this week
• by Lee, Tak-Sun Feb 16, 2021 06:07am

• Policy
• Fosamax 10mg·Pletaal OD Tab has been withdrawn
• by Lee, Tak-Sun Feb 16, 2021 06:07am

• Company
• RRMS, actively expanding coverage of drugs
• by Eo, Yun-Ho Feb 16, 2021 06:07am

• Policy
• The redemption of α-GPC benefits extended until March 15
• by Lee, Hye-Kyung Feb 15, 2021 06:17am

• Policy
• NHIS refuses to disclose immunotherapy reevaluation result
• by Moon, sung-ho Feb 15, 2021 06:16am